Mental Effects of Analgesic Drugs: Paracetamol and Ibuprofen

  • STATUS
    Recruiting
  • participants needed
    150
  • sponsor
    Prof. Jürgen Brockmöller
Updated on 5 August 2020
body mass index
ibuprofen
analgesics
imaging of brain

Summary

The objective of the present study is to study paracetamol effects on social pain and empathy under standardized international conditions (ICH-GCP) for planning, conduction and reporting of clinical pharmaceutical studies in humans. The study included MRI imaging of brain activity, analysis of genomic biomarkers potentially explaining interindividual variation. It is controversial whether the effects are of immediate nature or develop during a period of about 10 days. Therefore, the study is separated into two study phases. Single dosing (SD) is applied in study phase 1 and multiple-dosing (MD) in study phase 2. The study compares paracetamol with placebo and in the study phase 1 also with ibuprofen as analgetically active control.

Details
Condition Emotional Intelligence, Empathy
Age 18years - 50years
Treatment Placebo Oral Tablet, Paracetamol, Ibuprofen
Clinical Study IdentifierNCT04424420
SponsorProf. Jürgen Brockmöller
Last Modified on5 August 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Written informed consent obtained prior to study
Willingness to meet the study instructions and to co-operate with the study personal
No clinically relevant pathological findings in any of the investigations at the screening visit; minor deviations of laboratory values from the normal range may be accepted if judged by the investigator to have no clinical relevance
Body weight not less than 48 kg and body mass index (BMI) not less than 17 kg/m and not greater than 32 kg/m

Exclusion Criteria

Pacemaker devices, implantable or external ones
Involvement in the planning and conduct of the study (applies to staff directly employed at the study site / department)
Known pregnancy or lactation period
History of alcohol and / or drug abuse and / or any abusive use of medicaments
Any disease affecting liver or kidney or impairment of the liver or kidney-function
History of severe hypersensitivity reactions, anaphylaxis, psychiatric or neurologic disorder
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.